NEW YORK (GenomeWeb News) - Neuromed has licensed an Aureus Pharma database for use in its drug-development programs, Aureus said today.
 
Under the agreement, Neuromed will use the company’s AurScope Ion Channel database to support development of its chronic pain drugs.
 
AurScope contains information from the scientific literature that can be used to study "all known" ion channels that apply to "all stages of the drug discovery process," Aureus said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.